EMFAT
Emerald Mutual Fund Advisers Trust’s Transmedics TMDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $34.3M | Sell |
255,643
-6,928
| -3% | -$928K | 2.09% | 5 |
|
|
2025
Q1 | $17.7M | Buy |
262,571
+43,296
| +20% | +$2.91M | 1.25% | 27 |
|
|
2024
Q4 | $13.7M | Buy |
219,275
+94,034
| +75% | +$5.86M | 0.83% | 47 |
|
|
2024
Q3 | $19.7M | Sell |
125,241
-123,816
| -50% | -$19.4M | 1.02% | 34 |
|
|
2024
Q2 | $37.5M | Sell |
249,057
-165,457
| -40% | -$24.9M | 1.97% | 5 |
|
|
2024
Q1 | $30.6M | Buy |
414,514
+425
| +0.1% | +$31.4K | 1.6% | 10 |
|
|
2023
Q4 | $32.7M | Buy |
414,089
+57,342
| +16% | +$4.53M | 1.73% | 10 |
|
|
2023
Q3 | $19.5M | Buy |
356,747
+2,285
| +0.6% | +$125K | 1.18% | 21 |
|
|
2023
Q2 | $29.8M | Buy |
354,462
+1,089
| +0.3% | +$91.5K | 1.61% | 7 |
|
|
2023
Q1 | $26.8M | Sell |
353,373
-88,418
| -20% | -$6.7M | 1.58% | 8 |
|
|
2022
Q4 | $27.3M | Buy |
441,791
+57,344
| +15% | +$3.54M | 1.69% | 6 |
|
|
2022
Q3 | $16M | Buy |
384,447
+37,098
| +11% | +$1.55M | 1.01% | 37 |
|
|
2022
Q2 | $10.9M | Buy |
347,349
+74,944
| +28% | +$2.36M | 0.63% | 62 |
|
|
2022
Q1 | $7.34M | Sell |
272,405
-28,087
| -9% | -$757K | 0.32% | 101 |
|
|
2021
Q4 | $5.76M | Sell |
300,492
-40,000
| -12% | -$766K | 0.2% | 120 |
|
|
2021
Q3 | $11.3M | Sell |
340,492
-28,767
| -8% | -$952K | 0.39% | 86 |
|
|
2021
Q2 | $12.3M | Sell |
369,259
-231,380
| -39% | -$7.68M | 0.4% | 94 |
|
|
2021
Q1 | $24.9M | Buy |
600,639
+18,125
| +3% | +$752K | 0.83% | 46 |
|
|
2020
Q4 | $11.6M | Sell |
582,514
-25,423
| -4% | -$506K | 0.4% | 98 |
|
|
2020
Q3 | $8.38M | Hold |
607,937
| – | – | 0.37% | 84 |
|
|
2020
Q2 | $10.9M | Buy |
607,937
+183,465
| +43% | +$3.29M | 0.51% | 68 |
|
|
2020
Q1 | $5.13M | Sell |
424,472
-5,396
| -1% | -$65.2K | 0.32% | 99 |
|
|
2019
Q4 | $8.17M | Buy |
429,868
+233,358
| +119% | +$4.44M | 0.33% | 104 |
|
|
2019
Q3 | $4.67M | Hold |
196,510
| – | – | 0.21% | 135 |
|
|
2019
Q2 | $5.7M | Buy |
+196,510
| New | +$5.7M | 0.23% | 129 |
|